Skip to main content

Table 1 Clinical characteristics of the patients and healthy control

From: RETRACTED ARTICLE: Downregulation of miR-483-5p decreases hypoxia-induced injury in human cardiomyocytes by targeting MAPK3

Variables

AMI (n = 20)

Control (n = 20)

Age (mean ± SD)

65.3 ± 7.4

70.4 ± 8.2

Gender (male/female)

13/7

9/11

CK-MB (ng/mL)

38.95 ± 1.35

18.23 ± 3.64

cTnI (ng/mL)

1.35 ± 1.24

0.08 ± 0.02

HDL (mmol/L)

1.16 ± 1.03

1.32 ± 0.28

LDL (mmol/L)

2.71 ± 0.97

2.64 ± 0.84

TC (mmol/L)

4.27 ± 0.34

3.57 ± 0.75

TG (mmol/L)

1.72 ± 0.65

1.46 ± 0.42

Medical history

 Hypertension (n, %)

14 (70%)

13 (65%)

 Diabetes mellitus (n, %)

8 (40%)

6 (30%)

 Hypercholesterolemia (n, %)

9 (45%)

8 (40%)

 Arrhythmia (n, %)

2 (10%)

3 (15%)

Blood pressure

 Systolic blood pressure (mmHg)

124 ± 16

130 ± 18

 Diastolic blood pressure (mmHg)

81 ± 9

78 ± 12

  1. CK-MB creatine kinase MB isoform, cTnI cardiac troponin I, TC total cholesterol, TG total glyceride, HDL high-density lipoprotein, LDL low-density lipoprotein